Delhi-based health tech startup RxMen has raised Rs 5 crore (about $570K) in a seed round led by Inflection Point Ventures (IPV). SPA Family Ventures, Ankit Goel, and Seven Square Ventures also joined the round, along with a grant from Prosus Group. This early-stage backing highlights growing investor confidence in India’s emerging men’s health ecosystem.
The startup plans to use the fresh funds to build its brand, launch RxMen-branded health products, and set up co-branded physical clinics. With these moves, the firm has set its sights on achieving positive EBITDA by October 2025.
A vision to change men’s health
Founded in 2023 by Shailja Mittal, RxMen positions itself as a full-stack, clinic-led men’s health platform. Unlike fragmented solutions that treat symptoms, RxMen focuses on root-cause treatment. Its platform covers sexual health, hormonal balance, skin, stress, and sleep—domains often overlooked in men’s wellness conversations.
Mittal and her team saw a glaring gap in the healthcare system: men often ignore early health issues, especially around sexual or mental well-being, because of stigma. RxMen addresses this with confidentiality, clinical expertise, and technology-driven tools that encourage men to seek timely help.
Rapid growth in just 20 months
In less than two years, RxMen has scaled at a pace rarely seen in early-stage healthcare ventures. Over the past 20 months, the startup claims 100x revenue growth. By August 2025, RxMen reached a monthly recurring revenue (MRR) of $70,000 and projects an annual run rate (ARR) of $1.7 million for FY26.
The firm has already facilitated more than 30,000 consultations. Today, it manages over 6,000 consultations every month, powered by a network of 30 specialists across urology, psychiatry, sexology, and therapy. This hybrid model blends digital accessibility with clinical credibility, making it stand out in a crowded health-tech landscape.
Building proprietary health tools
One of RxMen’s most unique innovations is the Sexual Health Index (SHI). Built using data from over 25,000 anonymized consultations, the SHI measures multiple dimensions of male sexual health and helps doctors design better treatment paths. IIT Jodhpur is currently validating the tool, which adds scientific backing to RxMen’s approach.
The startup reports a 95% success rate in treatment outcomes guided by SHI. If validated, this metric could set a new benchmark in standardized men’s health diagnostics, similar to how BMI or blood pressure became standard references in general health.
Investor confidence in the model
Inflection Point Ventures, one of India’s most active early-stage investors, saw potential in RxMen’s blend of clinics, tech, and proprietary health metrics. The participation of SPA Family Ventures, Ankit Goel, and Seven Square Ventures adds strategic depth, while Prosus Group’s grant underscores RxMen’s credibility in leveraging technology for social good.
Investors believe the men’s health market is ripe for disruption. India has a young population, rising awareness of preventive care, and increasing comfort with telemedicine. Yet men’s health remains a largely under-served segment. By focusing on taboo topics like sexual health and stress, RxMen taps into unmet demand with a differentiated approach.
Market opportunity and competition
The Indian men’s health and wellness market is worth billions of dollars and is expanding at a double-digit growth rate. Most solutions in this space focus on quick fixes—supplements, hair regrowth products, or over-the-counter solutions. RxMen, however, is betting on holistic treatment, combining clinical consultations with lifestyle products.
Its main competitors include Man Matters (from Mosaic Wellness), Bold Care, and Traya. Man Matters has gained traction through a strong direct-to-consumer (D2C) play, while Bold Care and Traya have leaned on tele-consultations and personalized regimens. RxMen differentiates itself with its clinic-led model and SHI, creating a bridge between digital convenience and medical reliability.
Clinics at the center of growth
RxMen plans to establish co-branded clinics as part of its next phase of expansion. These clinics will offer patients direct access to specialists in an environment designed for men’s health needs. By combining physical presence with digital engagement, RxMen aims to deepen trust, improve treatment adherence, and increase repeat consultations.
The hybrid model also helps RxMen build defensibility in a market where many D2C health startups struggle with customer stickiness. Clinics not only add a revenue stream but also serve as trust-building touchpoints in a category often surrounded by stigma.
Road to profitability
With its strong revenue trajectory and patient base, RxMen has outlined a clear path toward profitability. The company aims to turn EBITDA-positive by October 2025. This timeline demonstrates discipline in scaling responsibly while keeping financial sustainability in focus.
By investing in brand-building and new products, RxMen wants to evolve from a services platform into a holistic men’s health brand. The expansion into branded products also diversifies revenue beyond consultations, adding higher-margin categories like supplements, wellness kits, and dermatology solutions.
Broader impact on men’s wellness
Men’s health has long been an under-addressed area in India, often overshadowed by maternal and child health or generalized wellness programs. RxMen’s rise highlights a cultural shift where men are more willing to discuss sensitive health concerns.
The company’s emphasis on stress and sleep management, along with hormonal and sexual health, reflects a broader understanding of wellness. It doesn’t treat these as isolated issues but as interconnected elements of overall well-being. This holistic view aligns with global trends in personalized healthcare.
Challenges ahead
Despite strong momentum, RxMen faces several challenges. Scaling clinics across multiple cities requires capital and operational expertise. Competitors with deeper pockets may respond with aggressive marketing. Stigma around men’s health, particularly sexual health, still exists and requires sustained awareness campaigns.
Regulatory scrutiny in health tech is another factor. With the SHI under validation, RxMen must ensure scientific credibility while scaling its platform responsibly. Any misstep could slow down adoption in a category where trust is fragile.
What makes RxMen different
RxMen’s biggest strength lies in combining medical credibility with patient-friendly access. Unlike purely e-commerce health platforms, it puts clinics and doctors at the core of the patient journey. Unlike traditional clinics, it uses AI, data, and proprietary tools like SHI to personalize care.
This dual approach—clinical trust and digital efficiency—gives RxMen an edge. By collecting real-world health data at scale, it can also pioneer research in men’s health, creating a feedback loop that improves outcomes and drives innovation.
Conclusion
RxMen’s Rs 5 crore seed funding marks an important step in India’s evolving men’s health ecosystem. In just 20 months, the company has grown 100x in revenue, facilitated over 30,000 consultations, and built a network of 30 specialists. With the Sexual Health Index under validation, a clear plan to launch clinics, and EBITDA positivity in sight by 2025, RxMen stands poised to redefine men’s health in India.
As awareness grows and stigma declines, platforms like RxMen can bridge the gap between neglected health needs and accessible care. If it sustains its momentum, RxMen may not only compete with Man Matters, Bold Care, and Traya but also set new standards in holistic men’s health solutions.
Also Read – Google for Startups Accelerator Africa 2025: A Big Push for Innovation